Early Treatment Versus Expectant Management of PDA in Preterm Infants
Randomized Non-inferiority Trial of Early Treatment Versus Expectant Management of Patent Ductus Arteriosus in Preterm Infants
Sponsor: Lviv National Medical University
A NA clinical study on Patent Ductus Arteriosus, this trial is completed. The trial is conducted by Lviv National Medical University and has accumulated 7 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2022 — Jul 2024 [monthly]
Completed NA
-
Sep 2021 — May 2022 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Oct 2020 — Jan 2021 [monthly]
Recruiting NA
-
Apr 2019 — Oct 2020 [monthly]
Recruiting NA
First recorded
Feb 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Lviv National Medical University
For direct contact, visit the study record on ClinicalTrials.gov .